Literature DB >> 7612044

High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane.

S B Cohen1, P D Katsikis, C Q Chu, H Thomssen, L M Webb, R N Maini, M Londei, M Feldmann.   

Abstract

OBJECTIVE: To characterize the cytokine profile of the activated T cell population derived from the synovial membrane of rheumatoid arthritis (RA) patients.
METHODS: Interleukin-2 (IL-2) was used to select for in vivo-activated T cells from the synovial membrane of 2 patients with RA, and the cells were cloned nonspecifically. The cytokine production profile of these clones was compared with that of clones derived from peripheral blood monocytes (PBM) by stimulating all clones for 24 hours with immobilized anti-CD3 (coated at 10 micrograms/ml) or phorbol-12-myristate-13-acetate (10 ng/ml) plus soluble anti-CD3 (1 microgram/ml). Interferon-gamma (IFN gamma), IL-4, and IL-10, the cytokines that discriminate between Th1 and Th2 cells and are involved in immunoregulation, were assayed by enzyme-linked immunosorbent assay.
RESULTS: There was a difference in the cytokines produced by the clones derived from the rheumatoid membranes compared with clones derived from the periphery. Clones derived from both membranes and PBM were mostly IFN gamma-producers, i.e., either a Th0 or a Th1 profile. There was a high proportion of IFN gamma/high IL-10-producing cells derived from the joint, but not from the periphery. Of clones derived from the synovial membrane of each of 2 RA patients, 100% and 50% produced both 1-10 ng/ml IFN gamma and > 7 ng/ml IL-10, compared with < 7% of clones derived from normal or RA peripheral blood. In addition, when autologous membrane and PBM were compared, the mean concentration of IL-10 produced by the clones derived from the synovial membrane sample was significantly different from those produced by clones derived from peripheral blood (P < 0.02).
CONCLUSION: The cytokine profile of the T cell clones that were obtained from the RA joint after expansion with IL-2 is distinct from that of the T cells that are predominant in PBM. This supports the concept that the T cells subsets that accumulate in the joint are not a random sample. The high level of IL-10 production by clones derived from the synovium suggests that this cytokine may be a major contributor to the endogenous immunosuppression that occurs in RA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7612044     DOI: 10.1002/art.1780380710

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  29 in total

1.  Interleukin 10 treatment for rheumatoid arthritis.

Authors:  E W St Clair
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

3.  Expression of cytokine mRNA in lentivirus-induced arthritis.

Authors:  F Lechner; H R Vogt; H F Seow; G Bertoni; W P Cheevers; U von Bodungen; A Zurbriggen; E Peterhans
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 4.  Cytokine therapy in rheumatoid arthritis.

Authors:  J Hermann; M Walmsley; F M Brennan
Journal:  Springer Semin Immunopathol       Date:  1998

5.  The method of deriving human T-cell clones alters the proportion of IL-10-producing cells.

Authors:  S B Cohen; L M Webb; M Feldmann
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

6.  Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2.

Authors:  S B Cohen; J B Crawley; M C Kahan; M Feldmann; B M Foxwell
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

7.  Absence of peripheral blood T cell responses to "shared epitope' containing peptides in recent onset rheumatoid arthritis.

Authors:  G J McColl; J Hammer; L C Harrison
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

8.  Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.

Authors:  Juliana Maia Teixeira; Henrique Ballassini Abdalla; Rosanna Tarkany Basting; Bruce D Hammock; Marcelo Henrique Napimoga; Juliana Trindade Clemente-Napimoga
Journal:  Int Immunopharmacol       Date:  2020-07-28       Impact factor: 4.932

Review 9.  Role of pro-inflammatory cytokines in rheumatoid arthritis.

Authors:  F M Brennan; R N Maini; M Feldmann
Journal:  Springer Semin Immunopathol       Date:  1998

10.  IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity?

Authors:  J R de la Vega; J C Vilaplana; A Biro; L Hammond; G F Bottazzo; R Mirakian
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.